Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy
M. Toth et al., Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy, J ENDOC INV, 23(5), 2000, pp. 287-294
Patients with non-hyperfunctioning adrenal adenomas often have an increased
plasma 17-hydroxyprogesterone response to ACTH stimulation. The effects of
adrenal surgery on this abnormality have rarely been investigated. One hun
dred and sixty-one patients with unilateral adrenal tumors (non-hyperfuncti
oning adenomas, 78; cortisol-producing adenomas, 8; aldosterone-producing a
denomas, 37; adrenal cysts, 12; pheochromocytomas, 26) were studied. Patien
ts before and after adrenal surgery as well as 60 healthy subjects underwen
t an ACTH stimulation test using 2 mg synthetic ACTH(1-24) (Cortrosyn Depot
, Organon). Basal and ACTH-stimulated plasma 17-hydroxyprogesterone and cor
tisol concentrations are reported. Before adrenal surgery, the basal plasma
17-hydroxyprogesterone concentrations were normal in patients with all typ
es of tumors. However, the ACTH-stimulated plasma 17-hydroxyprogesterone le
vels were abnormally increased in 53% and 31% of patients with non-hyperfun
ctioning adenomas and aldosterone-producing adenomas, respectively. In addi
tion, a few patients with adrenal cysts and pheochromocytomas also showed a
n increased ACTH-stimulated 17-hydroxyprogesterone response. After unilater
al adrenalectomy, this hormonal abnormality disappeared in most, although n
ot all patients with adrenal tumors. In patients with non-hyperfunctioning
adrenal tumors, ACTH-stimulated plasma 17-hydroxyprogesterone and cortisol
concentrations significantly correlated with the size of the tumors. These
results firmly indicate that the tumoral mass itself may be responsible for
the increased plasma 17-hydroxyprogesterone and cortisol responses after A
CTH stimulation in patients with non-hyperfunctioning and hyperfunctioning
adrenal adenomas. (C) 2000. Editrice Kurtis.